Title : Phase II study of cediranib in patients with malignant pleural mesothelioma: SWOG S0509.

Pub. Date : 2011 Nov

PMID : 21964533






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 We conducted a phase II study of the oral pan-VEGF receptor tyrosine kinase inhibitor, cediranib, in patients with MPM after platinum-based systemic chemotherapy. Platinum vascular endothelial growth factor A Homo sapiens